Hyperoxia Activates NF-κB and Increases TNF-α and IFN-γ Gene Expression in Mouse Pulmonary Lymphocytes

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 3902-3908

  Shea, Lytitia M ^a,c   Beehler, Connie ^b   Schwartz, Michael ^b   Shenkar, Robert ^b   Tuder, Rubin ^b   Abraham, Edward ^b  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HYPEROXIA; IMMUNOLOGY; LUNG; LUNG LAVAGE; METABOLISM; MOUSE; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION; HYPEROXIA; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED BALB C; NF-KAPPA B; POLYMERASE CHAIN REACTION; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030294357     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Nash, G., J. B. Blennerhassett, and H. Pontoppidan. 1967. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N. Engl. J. Med. 267: 368.
2. Cedergren, B., L. Gyllensten, and J. Wersäll. 1959. Pulmonary damage caused by oxygen poisoning: an electron-microscopic study in mice. Acta Paediatr. 48:477.
3. Clark, J. M., and C. J. Lambertsen. 1971. Pulmonary oxygen toxicity: a review. Pharmacol. Rev. 23:37.
4. Kapanci, Y., E. R. Weibel, H. P. Kaplan, and F. R. Robinson. 1969. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ullrastructural and morphometric studies. Lab. Invest. 20:101.
5. Kaplan, H. P., F. R. Robinson, Y. Kapanci, and E. R. Weibel. 1969. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. I. Clinical and light microscopic studies. Lab. Invest. 20:94.
6. Jensen, J. C., H. W. Pogrebniak, H. I. Pass, C. Buresh, M. J. Merino, D. Kauffman, D. Venzon, H. N. Langstein, and J. A. Norton. 1992. Role of tumor necrosis factor in oxygen toxicity. J. Appl. Physiol. 72:1902.
7. Yusa, T., J. D. Crapo, and B. A. Freeman. 1984. Hyperoxia enhances lung and liver nuclear superoxide generation. Biochim. Biophys. Acta 798:167.
8. Turrens, J. F., B. A. Freeman, J. G. Levitt, and J. D. Crapo. 1982. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 217:401.
9. Freeman, B. A., and J. D. Crapo. 1981. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 256:10986.
10. Byran, C. L., and S. G. Jenkinson. 1988. Oxygen toxicity. Clin. Chest Med. 9:141.
11. Deneke, S. M., and B. L. Fanburg. 1980. Normobaric oxygen toxicity of the lung. N. Engl. J. Med. 303:76.
12. Frank, L., and D. Massaro. 1980. Oxygen toxicity. Am. J. Med. 69:117.
13. Lavelle, F., A. M. Michelson, and L. Dimitrijevic. 1973. Biological protection by superoxide dismutase. Biochem. Biophys. Res. Commun. 55:350.
14. Yam, J., L. Frank, and R. J. Roberts. 1978. Oxygen toxicity: comparison of lung biochemical responses in neonatal and adult rats. Pediatr. Res. 12:115.
15. Kimball, R. E., K. Reddy, T. H. Peirce, L. W. Schwartz, M. G. Mustafa, and C. E. Cross. 1976. Oxygen toxicity: augmentation of anti-oxidant defense mechanisms in rat lung. Am. J. Physiol. 230:1425.
16. Warshaw, J. B., C. W. Wilson III, K. Saito, and R. A. Prough. 1985. The responses of glutathione and antioxidant enzymes to hyperoxia in developing lung. Pediatr. Res. 19:819.
17. Freeman, B. A., R. J. Mason, M. C. Williams, and J. D. Crapo. 1986. Antioxidant enzyme activity in alveolar type II cells after exposure of rats to hyperoxia. Exp. Lung Res. 10:203.
18. Crapo, J. D., and D. F. Tiemey. 1974, Superoxide dismutase and pulmonary oxygen toxicity. Am. J. Physiol. 226:1401.
19. Turrens, J. F., J. D. Crapo, and B. A. Freeman. 1984. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J. Clin. Invest. 73:87.
20. White, C. W., J. H. Jackson, A. Abuchowski, J. M. McCord, and J. E. Repine. 1984. Intravenous treatment with polyethylene glycol (PEG)-conjugated superoxide dismutase (SOD) and catalase (CAT) prolongs survival of rats exposed to hyperoxia. Clin. Res. 32:60A (Abstr).
21. Padmanabhan, R. V., R. Gudapaly, I. E. Liener, B. A. Schwartz, and J. R. Hoidal. 1985. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am. Rev. Respir. Dis. 132:164.
22. Schreck, R., P. Rieber, and P. A. Baeuerle, 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247.
23. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as a secondary antioxidant responsive factor. EMBO J. 12:2005.
24. Los, M., W. Droge, K. Strieber, P. A. Baeuerle, and K. Schulze-Osthoff. 1995. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol. 25:159.
25. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor-alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498.
26. Hiscott, J., J. Marois, J. Garoufalis, M. D'Addario, A. Roulston, I. Kwan, N. Pepin, J. Lacoste, H. Nguyen, G. Bensi, and M. Fenton. 1993. Characterization of a functional NF-κB site in the human IL-1β promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:6231.
27. Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer. J. P. Ways, and J. G. Gray. 1994. NF-βB regulates IL-1β transcription through a consensus NF-βB binding site and a non-consensus CRE-like site. J. Immunol. 153:712.
28. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10:2327.
29. Kunsch, C., R. K. Lang, C. A. Rosen, and M. F. Shannon. 1994. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (Rel A): NF-IL-6. J. Immunol. 153:153.
30. Shenkar, R., M. D. Schwartz, L. S. Terada, J. E. Repine, J. McCord, and E. Abraham. 1996. Hemorrhage activates NF-κB in murine lung mononuclear cells in vivo. Am. J. Physiol. 270:L729.
31. Stall, F. J. T., M. Roederer, L. A. Herzenberg, and L. A. Herzenberg. 1990. Intracellular thiols regulate activation of NF-κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:9943.
32. Schreck, R., B. Meier, D. Männel, W. Dröge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of NF-κB activation in intact cells. J. Exp. Med. 175:1181.
33. Welty, S. E., J. L. Rivera, J. F. Ellision, C. V. Smith, T. Zeb, C. M. Ballantyne, C. A. Montgomery, and T. N. Hansen. 1993. Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am. J. Respir. Cell Mol. Biol. 9:393.
34. Barry, B. E., and J. D. Crapo. 1985. Patterns of accumulation of platelets and neutrophils in rat lungs during exposure to 100% and 85% oxygen. Am. Rev. Respir. Dis. 132:548.
35. Beehler, C. J., M. L. Simchuk, J. M. McCord, and J. E. Repine. 1992. Effects of dimethylthiourea in hyperoxic injury. J. Lab. Clin. Med. 119:508.
36. Robinson, A., and E. Abraham. 1991. Effects of hemorrhage and resuscitation on bacterial antigen-specific pulmonary plasma cell function. Crit. Care Med. 19: 1285.
37. Abraham, E., A. A. Freitas, and A. A. Coutinho. 1990. Purification and characterization of intraparenchymal lung lymphocytes. J. Immunol. 144:2117.
38. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
39. Kawasaki, E. S. 1990. Ampliation of RNA. In PCR Protocols: A Guide to Methods and Applications. M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, eds. Academic Press, New York, p. 21.
40. Shenkar, R., and E. Abraham. 1993. Effect of hemorrhage on cytokine gene transcription. Lymphokine Cytokine Res. 12:237.
41. Shenkar, R., W. F. Coulson, and E. Abraham. 1994. Hemorrhage and resuscitation induce alterations in cytokine expression and development of acute lung injury. Am. J. Respir. Cell Mol. Biol. 10:290.
42. Moore, K. W., P. Viera, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230.
43. Hillman, K., J. Qian, J. N. Siegel, G. Roderiquez, R. Blackburn, J. Manischewitz, M. Norcross, and H. Golding. 1992. Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway. J. Immunol. 148:3991.
44. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
45. Zabel, U., R. Schreck, and P. A. Bauerle. 1991. DNA binding of purified transcription factor NF-κB. J. Biol. Chem. 266:252.
46. Tanabe, O., S. Akira, T. Kamiya, G. G. Wong, T. Hirano, and T. Kishimoto. 1988. Genomic structure of the murine IL-6 gene: high degree of conservation of potential regulatory sequences between mouse and human. J. Immunol. 141: 3875.
47. Piret, B., S. Legrand-Poels, C. Sappey, and J. Piette. 1995. NF-κB transcription factor and human immunodeficiency virus type I (HIV-1) activation by methylene blue photosensitization. Eur. J. Biochem. 228:447.
48. Baeuerle, P. A. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072:63.
49. Shakhov, A. N., M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J. Exp. Med. 171:35.
50. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the TNF-α promoter in primary macrophages. J. Immunol. 147:1694.
51. Albrecht, H., L. B. Schook, and C. V. Johgeneel. 1995. Nuclear migration of NF-κB correlates with TNF-α mRNA accumulation. J. Inflamm. 45:64.
52. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765.
53. Kolesnick, R., and D. W. Golde. 1994. The sphingomyelin pathway in TNF and IL-1 signaling. Cell 77:325.
54. Johns, L. D., T. Sarr, and G. E. Ranges. 1994. Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-κB. J. Immunol. 152: 5877.
55. Singh, S., and B. B. Aggarwal. 1995. Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J. Biol. Chem. 270:24995.
56. Fugita, T., L. F. L. Reis, N. Watanabe, Y. Kimura, T. Taniguchi, and J. Vilček. 1989. Induction of the transcription factor IRF-1 and interferon 1-β mRNA by cytokines and activators of second messenger pathways. Proc. Nail. Acad. Sci. USA 86:9936.
57. Rein, T., M. Müller, and H. Zorbas 1994. In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res. 22:3033.
58. Bancroft, G. J., K. C. F. Sheehan, R. D. Schreiber, and E. R. Enanue. 1989. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in seid mice. J. Immunol. 143:127.
59. Ye, J., P. Ghosh, M Cippitelli, J. Subleski, K J. Hardy, J. R. Ortaldo, and H. A. Young. 1994. Characterization of a silencer regulatory element in the human interferon-γ promoter. J. Biol. Chem. 269:25728.
60. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245.
61. Rothlein, R., M. Czajkowski, M. M. O'Neill, S. D. Marlin, E. Mainolfi, and V. J. Merluzzi. 1988. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J. Immunol. 141:1665.
62. Wertheimer, S. J., C. L. Myers, R. W. Wallace, and T. P. Parks. 1992. Intercellular adhesion molecule-1 gene expression in human endothelial cells: differential regulation by tumor necrosis factor a and phorbol myristate acetate. J. Biol. Chem. 267:12030.
63. Baldwin, A. S. 1996. The NF-κB and I-κB proteins: new discoveries and insights. Annu. Rev. Immunol 14:649.